EU-Japan Biotech & Pharma Partnering Conference 2022

Lys Therapeutics, a french biotech company developing first-in-class biotherapies against neurological diseases and Grand-Prix i-Lab 2021, is announcing to participating to the EU-Japan Biotech & Pharma Partnering Conference 2022.

Don’t hesitate to reach Philippe Dujardin (CFO) and Dr. Manuel BLANC (CEO) for partnering discussions!

💻 Online 🗓 from 26-30 September 2022
📍 Onsite Partnering in Osaka 🗓 on 11 October 2022
https://bio-pharma-osaka-2022.b2match.io/

#BioJapan #DrugDiscoveryJapan #europeanEuropeNetwork #EUJapancenter #biotechnology #B2B #innovations #drugdiscovery #biotech #pharma #drug #Alliances #BusinessDevelopment #LysTherapeutics #CNS #NeurovascularDisorders #NeurodegenerativeDisorders

The event is co-organised by the Osaka Prefectural Government, the EU-Japan Centre for Industrial Cooperation and the Enterprise Europe Network. It will be supported by various Bioclusters from Japan and Europe including CCI Normandie, CCI de région Auvergne-Rhône-Alpes and Pôle Lyonbiopôle.